Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Carfenazine

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Carfenazine
Clinical data
Other namesProketazine, Carphenazin
License data
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • Withdrawn
Identifiers
  • 1-(10-{3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl}-10H-phenothiazin-2-yl)propan-1-one
CAS Number
PubChemCID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.018.249Edit this at Wikidata
Chemical and physical data
FormulaC24H31N3O2S
Molar mass425.59 g·mol−1
3D model (JSmol)
  • CCC(=O)c1ccc2Sc3ccccc3N(CCCN4CCN(CCO)CC4)c2c1
  • InChI=1S/C24H31N3O2S/c1-2-22(29)19-8-9-24-21(18-19)27(20-6-3-4-7-23(20)30-24)11-5-10-25-12-14-26(15-13-25)16-17-28/h3-4,6-9,18,28H,2,5,10-17H2,1H3
  • Key:XZSMZRXAEFNJCU-UHFFFAOYSA-N

Carfenazine (INN; former development codeWY-2445;BANcarphenazine;USANcarphenazine maleate; brand nameProketazine; former development codeNSC-71755) is anantipsychotic andtranquilizer of thephenothiazine group that was withdrawn from the market.[1][2][3]

Synthesis

[edit]
Thieme Synthesis:[4] Patent:[5][6]

The alkylation reaction between 2-propionyl phenothiazine (1) and1-bromo-3-chloropropane (2) gives 1-[10-(3-chloropropyl)phenothiazin-2-yl]propan-1-one (3). A second alkylation step, this time with 2-(1-Piperazinyl)ethanol (4), completes the synthesis of carfenazine (5).

Although above procedure is proof-of-concept, bear in mind noprotecting group.[clarification needed] Other patent uses ketalization technique.[clarification needed]

Analogs

[edit]

References

[edit]
  1. ^Elks J (14 November 2014).The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 224–.ISBN 978-1-4757-2085-3.
  2. ^William Andrew Publishing (22 October 2013).Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 862–.ISBN 978-0-8155-1856-3.
  3. ^Briggs GG, Freeman RK, Yaffe SJ (2011).Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Lippincott Williams & Wilkins. pp. 213–.ISBN 978-1-60831-708-0.
  4. ^Zhuraulev, S.V. et al, Zh. Obshch. Khim., 1962, 32, 2244
  5. ^M. H. Sherlock, N. Sperber,U.S. patent 2,985,654 (1961 toSchering)
  6. ^R. F. Tislow et al.,U.S. patent 3,023,146 (1962 toAmerican Home Products).


Typical
Disputed
Atypical
Others
α1
Agonists
Antagonists
α2
Agonists
Antagonists
β
Agonists
Antagonists
mAChRsTooltip Muscarinic acetylcholine receptors
Agonists
Antagonists
Precursors
(andprodrugs)
nAChRsTooltip Nicotinic acetylcholine receptors
Agonists
(andPAMsTooltip positive allosteric modulators)
Antagonists
(andNAMsTooltip negative allosteric modulators)
Precursors
(andprodrugs)
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
H1
Agonists
Antagonists
H2
Agonists
Antagonists
H3
Agonists
Antagonists
H4
Agonists
Antagonists
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Classes
Antidepressants
(Tricyclic antidepressants(TCAs))
Antihistamines
Antipsychotics
Anticonvulsants
Anticholinergics
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=Carfenazine&oldid=1329434716"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp